Production (Stage)
Purple Biotech Ltd
PPBT
$2.62
$0.0050.19%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | |||
|---|---|---|---|---|---|
| Net Income | 36.07% | 22.08% | 4.13% | ||
| Total Depreciation and Amortization | 2.08% | 0.00% | -4.00% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -75.11% | 65.18% | -380.15% | ||
| Change in Net Operating Assets | 8.28% | -188.07% | -33.67% | ||
| Cash from Operations | 21.76% | -2.01% | -36.27% | ||
| Capital Expenditure | -- | -- | -100.00% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -72.12% | 321.62% | -92.64% | ||
| Cash from Investing | -72.12% | 321.62% | -92.64% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -2.22% | -7.14% | 0.00% | ||
| Issuance of Common Stock | 50.80% | 9,250.00% | -99.41% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -39.34% | -101.42% | 6,793.75% | ||
| Cash from Financing | 61.57% | -93.69% | 642.31% | ||
| Foreign Exchange rate Adjustments | -150.00% | -104.26% | 335.00% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 23.16% | -632.36% | 70.69% | ||